|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07K 7/64 | |
| C07K 1/30 | |||
| A61K 38/13 | |||
| A61K 9/00 |
| (11) | Number of the document | 3067363 |
| (13) | Kind of document | T |
| (96) | European patent application number | 16156092.5 |
| Date of filing the European patent application | 2012-11-14 | |
| (97) | Date of publication of the European application | 2016-09-14 |
| (45) | Date of publication and mention of the grant of the patent | 2018-01-17 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 201161559830 P | 2011-11-15 | US |
| (72) |
Wu, Ke, US
Smith, Scott W., US
|
| (73) |
ALLERGAN, INC.,
2525 Dupont Drive, Irvine, CA 92612,
US
|
| (54) | A PROCESS FOR CRYSTALLIZATION OF CYCLOSPORIN A FORM 2 |
| A PROCESS FOR CRYSTALLIZATION OF CYCLOSPORIN A FORM 2 |